Division of Experimental Endoscopic Surgery, Imaging, Minimally Invasive Therapy & Technology, Department of Obstetrics and Gynaecology, Vito Fazzi Hospital, Lecce, Italy.
J Surg Oncol. 2012 Jun 15;105(8):835-40. doi: 10.1002/jso.22110. Epub 2011 Oct 10.
The prevention of lymphoceles was tested using collagen patch coated with the human coagulation factors (TachoSil) on 58 consecutive patients with endometrial cancer who had undergone hysterectomy and pelvic lymphadenectomy (PL).
Patients were randomized in two groups: standard technique plus TachoSil (30 patients, group 1) and standard technique only (28, group 2). All surgical parameters were collected and patients underwent ultrasound examination on postoperative days 7, 14, and 28. The main outcome measures were: the development of symptomatic or asymptomatic lymphoceles, the need for further surgical intervention, as adverse effect of surgery and the drainage volume and duration.
Same number of lymph nodes in both groups was removed; group 1 showed a lower drainage volume. Lymphoceles developed in 7 patients in group 1 and 16 in group 2, but only 3 were symptomatic in group 1 and 9 symptomatic in group 2, with statistical difference. Percutaneous drainage proved necessary in five cases: only one was in group 1 and four in group 2.
Intraoperative application of TachoSil reduced rate of postoperative lymphocysts after PL, and it seems to provide a useful additional treatment option for reducing drainage volume and preventing lymphocele development after PL.
在 58 例接受子宫切除术和盆腔淋巴结清扫术(PL)的子宫内膜癌患者中,使用涂有人凝血因子(TachoSil)的胶原贴预防淋巴囊肿,测试了其预防效果。
患者随机分为两组:标准技术加 TachoSil(30 例,组 1)和仅标准技术(28 例,组 2)。收集所有手术参数,并在术后第 7、14 和 28 天对患者进行超声检查。主要观察指标为:有症状或无症状的淋巴囊肿的发生、是否需要进一步手术干预、手术的不良反应以及引流量和引流时间。
两组的淋巴结数量相同;组 1 的引流量较低。组 1 有 7 例发生淋巴囊肿,组 2 有 16 例,但只有组 1 的 3 例出现症状,组 2 的 9 例出现症状,差异有统计学意义。有 5 例需要经皮引流:组 1 仅 1 例,组 2 4 例。
PL 术中应用 TachoSil 可降低术后淋巴囊肿的发生率,似乎为减少 PL 后引流量和预防淋巴囊肿的发生提供了一种有用的额外治疗选择。